论文部分内容阅读
在内分泌疾病中，女性性功能障碍主要表现为性感异常，本组发生率为３７．５０％，对照组６．６７％，差别非常显著（Ｐ＜０．０１）。性感异常发生率又以卵巢早衰居首（８０％），闭经次之（５８．３３％）。在ＦＳＨ、ＬＨ、ＰＲＬ、Ｅ２、Ｐ、Ｔ激素测定中，性欲低下与性高潮缺乏之激素水平无明显差异（Ｐ＞０．０５），但Ｅ２低值则与性功能障碍密切相关。经给予性激素、甲状腺素及肾上腺皮质激素等联合用药后，内分泌值恢复正常达９１．１１％，性欲低下和性高潮缺乏治愈率分别为８７．５０％和８４．６２％，临床效果满意。
In endocrine diseases, female sexual dysfunction mainly showed as abnormality, the incidence of this group was 37.50%, while the control group was 6.67%, the difference was very significant (P <0.01). The incidence of anomalous abnormalities again with premature ovarian failure (80%), followed by amenorrhea (58.33%). There was no significant difference in hormone levels of FSH, LH, PRL, E2, P, T between hypogonadism and orgasm (P> 0.05), but the low value of E2 was closely related to sexual dysfunction. After given sex hormones, thyroxine and adrenal cortex hormones and other combination therapy, the endocrine value returned to normal 91.11%, low sexual desire and orgasmic lack of cure rates were 87.50% and 84.62%, respectively, with satisfactory clinical results.